Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is -121.22.

Share Price ₹575.4Apr 25,2024
Market Cap ₹632.9 Cr
Earnings-TTM₹-5.2 CrTTM-Consolidated Results
Price/Earnings-121.22xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹632.9 Cr] as on Apr 25,2024

(/) Earnings [ ₹-5.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ -121.22x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay -121.22 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is -121.22x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 9.97x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 10.44x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2019 of 5.88x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS -5.22-121.22632.9
ADANI ENTERPRISES LTD3,751.7094.70355,270.0
REDINGTON LTD1,243.1114.0317,445.3
HONASA CONSUMER LTD77.66176.5113,707.4
MMTC LTD49.62225.7911,203.5
MSTC LTD239.5627.276,532.4
LLOYDS ENTERPRISES LTD132.2835.864,743.8
VERITAS (INDIA) LTD191.6220.964,016.7
NOVARTIS INDIA LTD95.5327.032,582.4
OPTIEMUS INFRACOM LTD53.2344.872,388.6
MISHTANN FOODS LTD26.0176.741,996.0

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -121.22x
Max industry PE 225.79x
Median industry PE 35.86x
Average industry PE 56.59x



You may also like the below Video Courses